Study: Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study
*Correspondence: Liang Yan, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Common GLP-1 Medications Explained Several GLP-1 medications are approved for use in the United States, including: Ozempic (semaglutide) Wegovy (also semaglutide, prescribed for weight management), Trulicity (dulaglutide) Victoza (liraglutide) These are available as weekly or daily injections and have seen a surge in demand, as new studies validate not just their effectiveness for diabetes but also for aiding weight loss
In the rest of this letter, for StayCurious Metabolism premium members, were going to dive into: How each of these peptides and bioregulators actually work Their real-world benefits, risks, and how people are using them Whats approved, for what indicationand whats not Consider this your no-BS guide to whats real, what mattersand whats coming.
doi: 10.3390/ijms25126298
Alcohol preferentially becomes the primary fuel source when present, shutting down fat oxidation pathways regardless of peptide signaling
